The three lives of viral fusion peptides

Chemistry and Physics of Lipids

Volumn 181, Issue , 2014, Pages 40-55

  Apellániz, Beatriz ^a   Huarte, Nerea ^a   Largo, Eneko ^a   Nieva, José L ^a  

^a CSIC UPV Unidad de Biofisica UBF   (Spain)

Author keywords

Fusion peptide; Membrane fusion; Peptide lipid interaction; Viral entry

Indexed keywords

F PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN GP 41; INFLUENZA VIRUS HEMAGGLUTININ; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; PEPTIDE;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BACULOVIRUS; CARBOXY TERMINAL SEQUENCE; CORONAVIRUS; EBOLA VIRUS; FILOVIRIDAE; FLAVIVIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; LIPID MEMBRANE; MEMBRANE FUSION; MEMBRANE STRUCTURE; NONHUMAN; ORTHOMYXOVIRUS; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETROVIRUS; REVIEW; RHABDOVIRUS; TOGAVIRUS; VIRUS ENTRY; VIRUS REPLICATION; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; MOLECULARLY TARGETED THERAPY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; GLYCOPROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL FUSION PROTEINS;

EID: 84899569805     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2014.03.003     Document Type: Review

References (190)

1. B. Adam, L. Lins, V. Stroobant, A. Thomas, and R. Brasseur Distribution of hydrophobic residues is crucial for the fusogenic properties of the Ebola virus GP2 fusion peptide J. Virol. 78 2004 2131 2136
2. A. Agirre, C. Flach, F.M. Goni, R. Mendelsohn, J.M. Valpuesta, F. Wu, and J.L. Nieva Interactions of the HIV-1 fusion peptide with large unilamellar vesicles and monolayers. A cryo-TEM and spectroscopic study Biochim. Biophys. Acta 1467 2000 153 164
3. B. Apellaniz, A. Garcia-Saez, S. Nir, and J.L. Nieva Destabilization exerted by peptides derived from the membrane-proximal external region of HIV-1 gp41 in lipid vesicles supporting fluid phase coexistence Biochim. Biophys. Acta 1808 2011 1797 1805
4. B. Apellaniz, A. Ivankin, S. Nir, D. Gidalevitz, and J.L. Nieva Membrane-proximal external HIV-1 gp41 motif adapted for destabilizing the highly rigid viral envelope Biophys. J. 101 2011 2426 2435
5. B. Apellaniz, J.L. Nieva, P. Schwille, and A.J. Garcia-Saez All-or-none versus graded: single-vesicle analysis reveals lipid composition effects on membrane permeabilization Biophys. J. 99 2010 3619 3628
6. B. Apellaniz, S. Nir, and J.L. Nieva Distinct mechanisms of lipid bilayer perturbation induced by peptides derived from the membrane-proximal external region of HIV-1 gp41 Biochemistry 48 2009 5320 5331
7. R.T. Armstrong, A.S. Kushnir, and J.M. White The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition J. Cell Biol. 151 2000 425 437
8. M. Backovic, and T.S. Jardetzky Class III viral membrane fusion proteins Curr. Opin. Struct. Biol. 19 2009 189 196
9. E. Baquero, A.A. Albertini, P. Vachette, J. Lepault, S. Bressanelli, and Y. Gaudin Intermediate conformations during viral fusion glycoprotein structural transition Curr. Opin. Virol. 3 2013 143 150
10. B. Barz, T.C. Wong, and I. Kosztin Membrane curvature and surface area per lipid affect the conformation and oligomeric state of HIV-1 fusion peptide: a combined FTIR and MD simulation study Biochim. Biophys. Acta 1778 2008 945 953
11. A.K. Bellamy-McIntyre, C.S. Lay, S. Baar, A.L. Maerz, G.H. Talbo, H.E. Drummer, and P. Poumbourios Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion J. Biol. Chem. 282 2007 23104 23116
12. I. Bloch, F.J. Quintana, D. Gerber, T. Cohen, I.R. Cohen, and Y. Shai T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif FASEB J. 21 2007 393 401
13. R. Blumenthal, and D.S. Dimitrov Targeting the sticky fingers of HIV-1 Cell 129 2007 243 245
14. R. Blumenthal, S. Durell, and M. Viard HIV entry and envelope glycoprotein-mediated fusion J. Biol. Chem. 287 2012 40841 40849
15. E. Borrego-Diaz, M.E. Peeples, R.M. Markosyan, G.B. Melikyan, and F.S. Cohen Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement Virology 316 2003 234 244
16. J. Brunner Testing topological models for the membrane penetration of the fusion peptide of influenza virus hemagglutinin FEBS Lett. 257 1989 369 372
17. V. Buzon, G. Natrajan, D. Schibli, F. Campelo, M.M. Kozlov, and W. Weissenhorn Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions PLoS Pathog. 6 2010 e1000880
18. V. Buzon, E. Padros, and J. Cladera Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study Biochemistry 44 2005 13354 13364
19. S. Castano, and B. Desbat Structure and orientation study of fusion peptide FP23 of gp41 from HIV-1 alone or inserted into various lipid membrane models (mono-, bi- and multibi-layers) by FT-IR spectroscopies and Brewster angle microscopy Biochim. Biophys. Acta 1715 2005 81 95
20. H. Chakraborty, P.K. Tarafdar, D.G. Klapper, and B.R. Lentz Wild-type and mutant hemagglutinin fusion peptides alter bilayer structure as well as kinetics and activation thermodynamics of stalk and pore formation differently: mechanistic implications Biophys. J. 105 2013 2495 2506
21. D.K. Chang, S.F. Cheng, and W.J. Chien The amino-terminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface J. Virol. 71 1997 6593 6602
22. D.K. Chang, S.F. Cheng, V. Deo Trivedi, and S.H. Yang The amino-terminal region of the fusion peptide of influenza virus hemagglutinin HA2 inserts into sodium dodecyl sulfate micelle with residues 16-18 at the aqueous boundary at acidic pH. Oligomerization and the conformational flexibility J. Biol. Chem. 275 2000 19150 19158
23. D.K. Chang, S.F. Cheng, E.A. Kantchev, C.H. Lin, and Y.T. Liu Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex BMC Biol. 6 2008 2
24. D.K. Chang, S.F. Cheng, C.H. Lin, E.B. Kantchev, and C.W. Wu Self-association of glutamic acid-rich fusion peptide analogs of influenza hemagglutinin in the membrane-mimic environments: effects of positional difference of glutamic acids on side chain ionization constant and intra- and inter-peptide interactions deduced from NMR and gel electrophoresis measurements Biochim. Biophys. Acta 1712 2005 37 51
25. J. Chen, J.J. Skehel, and D.C. Wiley N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil Proc. Natl. Acad. Sci. U.S.A. 96 1999 8967 8972
26. L.V. Chernomordik, and M.M. Kozlov Protein-lipid interplay in fusion and fission of biological membranes Annu. Rev. Biochem. 72 2003 175 207
27. F.S. Cohen, and G.B. Melikyan The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement J. Membr. Biol. 199 2004 1 14
28. A. Colotto, and R.M. Epand Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of influenza virus to perturb bilayers Biochemistry 36 1997 7644 7651
29. R.W. Doms, and J.P. Moore HIV-1 membrane fusion: targets of opportunity J. Cell Biol. 151 2000 F9 F14
30. J.E. Donald, Y. Zhang, G. Fiorin, V. Carnevale, D.R. Slochower, F. Gai, M.L. Klein, and W.F. DeGrado Transmembrane orientation and possible role of the fusogenic peptide from parainfluenza virus 5 (PIV5) in promoting fusion Proc. Natl. Acad. Sci. U.S.A. 108 2011 3958 3963
31. P.V. Dubovskii, H. Li, S. Takahashi, A.S. Arseniev, and K. Akasaka Structure of an analog of fusion peptide from hemagglutinin Protein Sci. 9 2000 786 798
32. S.R. Durell, I. Martin, J.M. Ruysschaert, Y. Shai, and R. Blumenthal What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review) Mol. Membr. Biol. 14 1997 97 112
33. P. Durrer, C. Galli, S. Hoenke, C. Corti, R. Gluck, T. Vorherr, and J. Brunner H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region J. Biol. Chem. 271 1996 13417 13421
34. D.M. Eckert, and P.S. Kim Mechanisms of viral membrane fusion and its inhibition Annu. Rev. Biochem. 70 2001 777 810
35. R.F. Epand, J.C. Macosko, C.J. Russell, Y.K. Shin, and R.M. Epand The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion J. Mol. Biol. 286 1999 489 503
36. R.M. Epand Fusion peptides and the mechanism of viral fusion Biochim. Biophys. Acta 1614 2003 116 121
37. R.M. Epand Further insights into the properties of the HIV gp41 fusion domain: commentary on the article by A.L. Lai et al J. Mol. Biol. 418 2012 1 2
38. R.M. Epand, J.J. Cheetham, R.F. Epand, P.L. Yeagle, C.D. Richardson, A. Rockwell, and W.F. Degrado Peptide models for the membrane destabilizing actions of viral fusion proteins Biopolymers 32 1992 309 314
39. R.M. Epand, and R.F. Epand Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayers Biochem. Biophys. Res. Commun. 202 1994 1420 1425
40. R.M. Epand, R.F. Epand, I. Martin, and J.M. Ruysschaert Membrane interactions of mutated forms of the influenza fusion peptide Biochemistry 40 2001 8800 8807
41. J. Fontana, G. Cardone, J.B. Heymann, D.C. Winkler, and A.C. Steven Structural changes in Influenza virus at low pH characterized by cryo-electron tomography J. Virol. 86 2012 2919 2929
42. W.G. Forssmann, Y.H. The, M. Stoll, K. Adermann, U. Albrecht, K. Barlos, A. Busmann, A. Canales-Mayordomo, G. Gimenez-Gallego, J. Hirsch, J. Jimenez-Barbero, D. Meyer-Olson, J. Munch, J. Perez-Castells, L. Standker, F. Kirchhoff, and R.E. Schmidt Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide Sci. Transl. Med. 2 2010 63re63
43. M.S. Freitas, C. Follmer, L.T. Costa, C. Vilani, M.L. Bianconi, C.A. Achete, and J.L. Silva Measuring the strength of interaction between the Ebola fusion peptide and lipid rafts: implications for membrane fusion and virus infection PLoS ONE 6 2011 e15756
44. M.S. Freitas, L.P. Gaspar, M. Lorenzoni, F.C. Almeida, L.W. Tinoco, M.S. Almeida, L.F. Maia, L. Degreve, A.P. Valente, and J.L. Silva Structure of the Ebola fusion peptide in a membrane-mimetic environment and the interaction with lipid rafts J. Biol. Chem. 282 2007 27306 27314
45. V.A. Frolov, and J. Zimmerberg Cooperative elastic stresses, the hydrophobic effect, and lipid tilt in membrane remodeling FEBS Lett. 584 2010 1824 1829
46. M. Fuhrmans, and S.J. Marrink Molecular view of the role of fusion peptides in promoting positive membrane curvature J. Am. Chem. Soc. 134 2012 1543 1552
47. C.M. Gabrys, W. Qiang, Y. Sun, L. Xie, S.D. Schmick, and D.P. Weliky Solid-state nuclear magnetic resonance measurements of HIV fusion peptide CO to lipid P proximities support similar partially inserted membrane locations of the alpha helical and beta sheet peptide Structures J. Phys. Chem. A 2013
48. S. Galdiero, A. Falanga, M. Vitiello, H. Browne, C. Pedone, and M. Galdiero Fusogenic domains in herpes simplex virus type 1 glycoprotein H J. Biol. Chem. 280 2005 28632 28643
49. S. Galdiero, M. Vitiello, M. D'Isanto, A. Falanga, M. Cantisani, H. Browne, C. Pedone, and M. Galdiero The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules Chembi: Eur. J. Chem. Biol. 9 2008 758 767
50. W.R. Gallaher Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus Cell 50 1987 327 328
51. R.F. Garry, and S. Dash Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins Virology 307 2003 255 265
52. J.K. Ghosh, and Y. Shai Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion J. Mol. Biol. 292 1999 531 546
53. U. Ghosh, L. Xie, and D.P. Weliky Detection of closed influenza virus hemagglutinin fusion peptide structures in membranes by backbone (13)CO- (15)N rotational-echo double-resonance solid-state NMR J. Biomol. NMR 55 2013 139 146
54. D.L. Gibbons, M.C. Vaney, A. Roussel, A. Vigouroux, B. Reilly, J. Lepault, M. Kielian, and F.A. Rey Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus Nature 427 2004 320 325
55. M.J. Gomara, M. Lorizate, N. Huarte, I. Mingarro, E. Perez-Paya, and J.L. Nieva Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion FEBS Lett. 580 2006 2561 2566
56. M.J. Gomara, P. Mora, I. Mingarro, and J.L. Nieva Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein FEBS Lett. 569 2004 261 266
57. L.M. Gordon, P.W. Mobley, W. Lee, S. Eskandari, Y.N. Kaznessis, M.A. Sherman, and A.J. Waring Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using 13C-enhanced Fourier transform infrared spectroscopy Protein Sci. 13 2004 1012 1030
58. L.M. Gordon, P.W. Mobley, R. Pilpa, M.A. Sherman, and A.J. Waring Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy Biochim. Biophys. Acta 1559 2002 96 120
59. D. Grasnick, U. Sternberg, E. Strandberg, P. Wadhwani, and A.S. Ulrich Irregular structure of the HIV fusion peptide in membranes demonstrated by solid-state NMR and MD simulations Eur. Biophys. J. 40 2011 529 543
60. C. Gray, S.A. Tatulian, S.A. Wharton, and L.K. Tamm Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers Biophys. J. 70 1996 2275 2286
61. S.M. Gregory, E. Harada, B. Liang, S.E. Delos, J.M. White, and L.K. Tamm Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2 Proc. Natl. Acad. Sci. U.S.A. 108 2011 11211 11216
62. J. Guillen, A.J. Perez-Berna, M.R. Moreno, and J. Villalain Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism J. Virol. 79 2005 1743 1752
63. X. Han, J.H. Bushweller, D.S. Cafiso, and L.K. Tamm Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin Nat. Struct. Biol. 8 2001 715 720
64. M.E. Haque, H. Chakraborty, T. Koklic, H. Komatsu, P.H. Axelsen, and B.R. Lentz Hemagglutinin fusion peptide mutants in model membranes: structural properties, membrane physical properties, and PEG-mediated fusion Biophys. J. 101 2011 1095 1104
65. M.E. Haque, V. Koppaka, P.H. Axelsen, and B.R. Lentz Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion Biophys. J. 89 2005 3183 3194
66. S.C. Harrison Viral membrane fusion Nat. Struct. Mol. Biol. 15 2008 690 698
67. T.A. Harroun, K. Balali-Mood, I. Gourlay, and J.P. Bradshaw The fusion peptide of simian immunodeficiency virus and the phase behaviour of N-methylated dioleoylphosphatidylethanolamine Biochim. Biophys. Acta 1617 2003 62 68
68. C. Harter, P. James, T. Bachi, G. Semenza, and J. Brunner Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the fusion peptide J. Biol. Chem. 264 1989 6459 6464
69. L.D. Hernandez, L.R. Hoffman, T.G. Wolfsberg, and J.M. White Virus-cell and cell-cell fusion Annu. Rev. Cell Dev. Biol. 12 1996 627 661
70. C.M. Horvath, and R.A. Lamb Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion J. Virol. 66 1992 2443 2455
71. N. Huarte, A. Araujo, R. Arranz, M. Lorizate, H. Quendler, R. Kunert, J.M. Valpuesta, and J.L. Nieva Recognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicity PLoS ONE 7 2012 e52740
72. N. Huarte, M. Lorizate, E. Perez-Paya, and J.L. Nieva Membrane-transferring regions of gp41 as targets for HIV-1 fusion inhibition and viral neutralization Curr. Top. Med. Chem. 11 2011 2985 2996
73. A. Ivankin, B. Apellaniz, D. Gidalevitz, and J.L. Nieva Mechanism of membrane perturbation by the HIV-1 gp41 membrane-proximal external region and its modulation by cholesterol Biochim. Biophys. Acta 1818 2012 2521 2528
74. C.P. Jaroniec, J.D. Kaufman, S.J. Stahl, M. Viard, R. Blumenthal, P.T. Wingfield, and A. Bax Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain Biochemistry 44 2005 16167 16180
75. J.P. Julien, S. Bryson, J.L. Nieva, and E.F. Pai Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site J. Mol. Biol. 384 2008 377 392
76. J.P. Julien, A. Cupo, D. Sok, R.L. Stanfield, D. Lyumkis, M.C. Deller, P.J. Klasse, D.R. Burton, R.W. Sanders, J.P. Moore, A.B. Ward, and I.A. Wilson Crystal structure of a soluble cleaved HIV-1 envelope trimer Science 342 2013 1477 1483
77. G.B. Karlsson Hedestam, R.A. Fouchier, S. Phogat, D.R. Burton, J. Sodroski, and R.T. Wyatt The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus Nat. Rev. Microbiol. 6 2008 143 155
78. P.K. Kinnunen, and J.M. Holopainen Mechanisms of initiation of membrane fusion: role of lipids Biosci. Rep. 20 2000 465 482
79. D.E. Klein, J.L. Choi, and S.C. Harrison Structure of a dengue virus envelope protein late-stage fusion intermediate J. Virol. 87 2013 2287 2293
80. Y. Kliger, A. Aharoni, D. Rapaport, P. Jones, R. Blumenthal, and Y. Shai Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study J. Biol. Chem. 272 1997 13496 13505
81. M.M. Kozlov, H.T. McMahon, and L.V. Chernomordik Protein-driven membrane stresses in fusion and fission Trends Biochem. Sci. 35 2010 699 706
82. P. Lague, B. Roux, and R.W. Pastor Molecular dynamics simulations of the influenza hemagglutinin fusion peptide in micelles and bilayers: conformational analysis of peptide and lipids J. Mol. Biol. 354 2005 1129 1141
83. A.L. Lai, A.E. Moorthy, Y. Li, and L.K. Tamm Fusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion J. Mol. Biol. 418 2012 3 15
84. A.L. Lai, H. Park, J.M. White, and L.K. Tamm Fusion peptide of influenza hemagglutinin requires a fixed angle boomerang structure for activity J. Biol. Chem. 281 2006 5760 5770
85. A.L. Lai, and L.K. Tamm Locking the kink in the influenza hemagglutinin fusion domain structure J. Biol. Chem. 282 2007 23946 23956
86. P. Larsson, and P.M. Kasson Lipid tail protrusion in simulations predicts fusogenic activity of influenza fusion peptide mutants and conformational models PLoS Comp. Biol. 9 2013 e1002950
87. W.L. Lau, D.S. Ege, J.D. Lear, D.A. Hammer, and W.F. DeGrado Oligomerization of fusogenic peptides promotes membrane fusion by enhancing membrane destabilization Biophys. J. 86 2004 272 284
88. 2 terminus of influenza HA-2 J. Biol. Chem. 262 1987 6500 6505
89. J.E. Lee, M.L. Fusco, A.J. Hessell, W.B. Oswald, D.R. Burton, and E.O. Saphire Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor Nature 454 2008 177 182
90. S. Legare, and P. Lague The influenza fusion peptide adopts a flexible flat V conformation in membranes Biophys. J. 102 2012 2270 2278
91. B.R. Lentz, V. Malinin, M.E. Haque, and K. Evans Protein machines and lipid assemblies: current views of cell membrane fusion Curr. Opin. Struct. Biol. 10 2000 607 615
92. Y. Li, X. Han, A.L. Lai, J.H. Bushweller, D.S. Cafiso, and L.K. Tamm Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion J. Virol. 79 2005 12065 12076
93. Y.L. Li, and L.K. Tamm Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers Biophys. J. 93 2007 876 885
94. M.L. Longo, A.J. Waring, L.M. Gordon, and D.A. Hammer Area expansion and permeation of phospholipid membrane bilayers by influenza fusion peptides and melittin Langmuir 14 1998 2385 2395
95. M.L. Longo, A.J. Waring, and D.A. Hammer Interaction of the influenza hemagglutinin fusion peptide with lipid bilayers: area expansion and permeation Biophys. J. 73 1997 1430 1439
96. J.L. Lorieau, J.M. Louis, and A. Bax The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface Proc. Natl. Acad. Sci. U.S.A. 107 2010 11341 11346
97. J.L. Lorieau, J.M. Louis, and A. Bax Helical hairpin structure of influenza hemagglutinin fusion peptide stabilized by charge-dipole interactions between the N-terminal amino group and the second helix J. Am. Chem. Soc. 133 2011 2824 2827
98. J.L. Lorieau, J.M. Louis, C.D. Schwieters, and A. Bax pH-triggered, activated-state conformations of the influenza hemagglutinin fusion peptide revealed by NMR Proc. Natl. Acad. Sci. U.S.A. 109 2012 19994 19999
99. M. Lorizate, I. de la Arada, N. Huarte, S. Sanchez-Martinez, B.G. de la Torre, D. Andreu, J.L. Arrondo, and J.L. Nieva Structural analysis and assembly of the HIV-1 Gp41 amino-terminal fusion peptide and the pretransmembrane amphipathic-at-interface sequence Biochemistry 45 2006 14337 14346
100. M. Lorizate, M.J. Gomara, B.G. de la Torre, D. Andreu, and J.L. Nieva Membrane-transferring sequences of the HIV-1 Gp41 ectodomain assemble into an immunogenic complex J. Mol. Biol. 360 2006 45 55
101. M. Lorizate, N. Huarte, A. Saez-Cirion, and J.L. Nieva Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission Biochim. Biophys. Acta 1778 2008 1624 1639
102. J. Luneberg, I. Martin, F. Nussler, J.M. Ruysschaert, and A. Herrmann Structure and topology of the influenza virus fusion peptide in lipid bilayers J. Biol. Chem. 270 1995 27606 27614
103. D. Lyumkis, J.P. Julien, N. de Val, A. Cupo, C.S. Potter, P.J. Klasse, D.R. Burton, R.W. Sanders, J.P. Moore, B. Carragher, I.A. Wilson, and A.B. Ward Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer Science 342 2013 1484 1490
104. J.C. Macosko, C.H. Kim, and Y.K. Shin The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR J. Mol. Biol. 267 1997 1139 1148
105. I. Martin, F. Defrise-Quertain, E. Decroly, M. Vandenbranden, R. Brasseur, and J.M. Ruysschaert Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes Biochim. Biophys. Acta 1145 1993 124 133
106. I. Martin, H. Schaal, A. Scheid, and J.M. Ruysschaert Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer J. Virol. 70 1996 298 304
107. G.B. Melikyan Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm Retrovirology 5 2008 111
108. M.N. Melo, F.J. Sousa, F.A. Carneiro, M.A. Castanho, A.P. Valente, F.C. Almeida, A.T. Da Poian, and R. Mohana-Borges Interaction of the Dengue virus fusion peptide with membranes assessed by NMR: the essential role of the envelope protein Trp101 for membrane fusion J. Mol. Biol. 392 2009 736 746
109. Y.S. Mendes, N.S. Alves, T.L. Souza, I.P. Sousa Jr., M.L. Bianconi, R.C. Bernardi, P.G. Pascutti, J.L. Silva, A.M. Gomes, and A.C. Oliveira The structural dynamics of the flavivirus fusion peptide-membrane interaction PLoS ONE 7 2012 e47596
110. P.W. Mobley, R. Pilpa, C. Brown, A.J. Waring, and L.M. Gordon Membrane-perturbing domains of HIV type 1 glycoprotein 41 AIDS Res. Hum. Retroviruses 17 2001 311 327
111. P.W. Mobley, A.J. Waring, M.A. Sherman, and L.M. Gordon Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs Biochim. Biophys. Acta 1418 1999 1 18
112. H. Mohanram, A. Nip, P.N. Domadia, A. Bhunia, and S. Bhattacharjya NMR structure, localization, and vesicle fusion of Chikungunya virus fusion peptide Biochemistry 51 2012 7863 7872
113. K.F. Morris, X. Gao, and T.C. Wong The interactions of the HIV gp41 fusion peptides with zwitterionic membrane mimics determined by NMR spectroscopy Biochim. Biophys. Acta 1667 2004 67 81
114. J. Munch, L. Standker, K. Adermann, A. Schulz, M. Schindler, R. Chinnadurai, S. Pohlmann, C. Chaipan, T. Biet, T. Peters, B. Meyer, D. Wilhelm, H. Lu, W. Jing, S. Jiang, W.G. Forssmann, and F. Kirchhoff Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide Cell 129 2007 263 275
115. I. Munoz-Barroso, K. Salzwedel, E. Hunter, and R. Blumenthal Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion J. Virol. 73 1999 6089 6092
116. H. Nemesio, F. Palomares-Jerez, and J. Villalain The membrane-active regions of the dengue virus proteins C and E Biochim. Biophys. Acta 1808 2011 2390 2402
117. J.L. Nieva, and A. Agirre Are fusion peptides a good model to study viral cell fusion? Biochim. Biophys. Acta 1614 2003 104 115
118. J.L. Nieva, S. Nir, A. Muga, F.M. Goni, and J. Wilschut Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage Biochemistry 33 1994 3201 3209
119. J.L. Nieva, and T. Suarez Hydrophobic-at-interface regions in viral fusion protein ectodomains Biosci. Rep. 20 2000 519 533
120. R.J. Owens, C.C. Tanner, M.J. Mulligan, R.V. Srinivas, and R.W. Compans Oligopeptide inhibitors of HIV-induced syncytium formation AIDS Res. Hum. Retroviruses 6 1990 1289 1296
121. J. Pan, C.B. Lai, W.R. Scott, and S.K. Straus Synthetic fusion peptides of tick-borne encephalitis virus as models for membrane fusion Biochemistry 49 2010 287 296
122. S.G. Peisajovich, R.F. Epand, R.M. Epand, and Y. Shai Sendai virus N-terminal fusion peptide consists of two similar repeats, both of which contribute to membrane fusion Eur. J. Biochem./FEBS 269 2002 4342 4350
123. S.G. Peisajovich, O. Samuel, and Y. Shai Paramyxovirus F1 protein has two fusion peptides: implications for the mechanism of membrane fusion J. Mol. Biol. 296 2000 1353 1365
124. S.G. Peisajovich, and Y. Shai Viral fusion proteins: multiple regions contribute to membrane fusion Biochim. Biophys. Acta 1614 2003 122 129
125. F.B. Pereira, F.M. Goni, A. Muga, and J.L. Nieva Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects Biophys. J. 73 1997 1977 1986
126. F.B. Pereira, F.M. Goni, and J.L. Nieva Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution FEBS Lett. 362 1995 243 246
127. F.B. Pereira, J.M. Valpuesta, G. Basanez, F.M. Goni, and J.L. Nieva Interbilayer lipid mixing induced by the human immunodeficiency virus type-1 fusion peptide on large unilamellar vesicles: the nature of the nonlamellar intermediates Chem. Phys. Lipids 103 1999 11 20
128. A.J. Perez-Berna, M.R. Moreno, J. Guillen, A. Bernabeu, and J. Villalain The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins Biochemistry 45 2006 3755 3768
129. M. Pritsker, P. Jones, R. Blumenthal, and Y. Shai A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion Proc. Natl. Acad. Sci. U.S.A. 95 1998 7287 7292
130. M. Pritsker, J. Rucker, T.L. Hoffman, R.W. Doms, and Y. Shai Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes Biochemistry 38 1999 11359 11371
131. S. Promsri, G.M. Ullmann, and S. Hannongbua Molecular dynamics simulation of HIV-1 fusion domain-membrane complexes: Insight into the N-terminal gp41 fusion mechanism Biophys. Chem. 170 2012 9 16
132. W. Qiang, M.L. Bodner, and D.P. Weliky Solid-state NMR spectroscopy of human immunodeficiency virus fusion peptides associated with host-cell-like membranes: 2D correlation spectra and distance measurements support a fully extended conformation and models for specific antiparallel strand registries J. Am. Chem. Soc. 130 2008 5459 5471
133. W. Qiang, Y. Sun, and D.P. Weliky A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide Proc. Natl. Acad. Sci. U.S.A. 106 2009 15314 15319
134. F.J. Quintana, D. Gerber, S.C. Kent, I.R. Cohen, and Y. Shai HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation J. Clin. Invest. 115 2005 2149 2158
135. M. Rafalski, J.D. Lear, and W.F. DeGrado Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41 Biochemistry 29 1990 7917 7922
136. M. Rafalski, A. Ortiz, A. Rockwell, L.C. van Ginkel, J.D. Lear, W.F. DeGrado, and J. Wilschut Membrane fusion activity of the influenza virus hemagglutinin: interaction of HA2 N-terminal peptides with phospholipid vesicles Biochemistry 30 1991 10211 10220
137. E.M. Reuven, Y. Dadon, M. Viard, N. Manukovsky, R. Blumenthal, and Y. Shai HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion Biochemistry 51 2012 2867 2878
138. S. Roche, S. Bressanelli, F.A. Rey, and Y. Gaudin Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G Science 313 2006 187 191
139. S. Roche, F.A. Rey, Y. Gaudin, and S. Bressanelli Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G Science 315 2007 843 848
140. K.H. Roux, and K.A. Taylor AIDS virus envelope spike structure Curr. Opin. Struct. Biol. 17 2007 244 252
141. M.B. Ruiz-Arguello, F.M. Goni, F.B. Pereira, and J.L. Nieva Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus J. Virol. 72 1998 1775 1781
142. K. Sackett, M.J. Nethercott, R.F. Epand, R.M. Epand, D.R. Kindra, Y. Shai, and D.P. Weliky Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations J. Mol. Biol. 397 2010 301 315
143. K. Sackett, M.J. Nethercott, Y. Shai, and D.P. Weliky Hairpin folding of HIV gp41 abrogates lipid mixing function at physiologic pH and inhibits lipid mixing by exposed gp41 constructs Biochemistry 48 2009 2714 2722
144. K. Sackett, and Y. Shai The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion Biochemistry 41 2002 4678 4685
145. K. Sackett, and Y. Shai How structure correlates to function for membrane associated HIV-1 gp41 constructs corresponding to the N-terminal half of the ectodomain J. Mol. Biol. 333 2003 47 58
146. K. Sackett, and Y. Shai The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: a 13C FTIR study J. Mol. Biol. 350 2005 790 805
147. K. Sackett, A. TerBush, and D.P. Weliky HIV gp41 six-helix bundle constructs induce rapid vesicle fusion at pH 3.5 and little fusion at pH 7.0: understanding pH dependence of protein aggregation, membrane binding, and electrostatics, and implications for HIV-host cell fusion Eur. Biophys. J. 40 2011 489 502
148. A. Saez-Cirion, J.L. Arrondo, M.J. Gomara, M. Lorizate, I. Iloro, G. Melikyan, and J.L. Nieva Structural and functional roles of HIV-1 gp41 pretransmembrane sequence segmentation Biophys. J. 85 2003 3769 3780
149. A. Saez-Cirion, and J.L. Nieva Conformational transitions of membrane-bound HIV-1 fusion peptide Biochim. Biophys. Acta 1564 2002 57 65
150. A. Saez-Cirion, S. Nir, M. Lorizate, A. Agirre, A. Cruz, J. Perez-Gil, and J.L. Nieva Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring J. Biol. Chem. 277 2002 21776 21785
151. K. Salzwedel, J.T. West, and E. Hunter A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity J. Virol. 73 1999 2469 2480
152. O. Samuel, and Y. Shai Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses Biochemistry 40 2001 1340 1349
153. S. Shnaper, K. Sackett, S.A. Gallo, R. Blumenthal, and Y. Shai The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively J. Biol. Chem. 279 2004 18526 18534
154. D.P. Siegel, and R.M. Epand The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanisms Biophys. J. 73 1997 3089 3111
155. D.P. Siegel, and R.M. Epand Effect of influenza hemagglutinin fusion peptide on lamellar/inverted phase transitions in dipalmitoleoylphosphatidylethanolamine: implications for membrane fusion
156. J.J. Skehel, and D.C. Wiley Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin Annu. Rev. Biochem 69 2000 531 569
157. V.A. Slepushkin, G.V. Kornilaeva, S.M. Andreev, M.V. Sidorova, A.O. Petrukhina, G.R. Matsevich, S.V. Raduk, V.B. Grigoriev, T.V. Makarova, and V.V. Lukashov et al. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein Virology 194 1993 294 301
158. E.C. Smith, S.M. Gregory, L.K. Tamm, T.P. Creamer, and R.E. Dutch Role of sequence and structure of the Hendra fusion protein fusion peptide in membrane fusion J. Biol. Chem. 287 2012 30035 30048
159. T. Suarez, W.R. Gallaher, A. Agirre, F.M. Goni, and J.L. Nieva Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion J. Virol. 74 2000 8038 8047
160. T. Suarez, M.J. Gomara, F.M. Goni, I. Mingarro, A. Muga, E. Perez-Paya, and J.L. Nieva Calcium-dependent conformational changes of membrane-bound Ebola fusion peptide drive vesicle fusion FEBS Lett. 535 2003 23 28
161. T. Suarez, S. Nir, F.M. Goni, A. Saez-Cirion, and J.L. Nieva The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence FEBS Lett. 477 2000 145 149
162. Y. Sun, and D.P. Weliky 13C-13C correlation spectroscopy of membrane-associated influenza virus fusion peptide strongly supports a helix-turn-helix motif and two turn conformations J. Am. Chem. Soc. 131 2009 13228 13229
163. Z.Y. Sun, K.J. Oh, M. Kim, J. Yu, V. Brusic, L. Song, Z. Qiao, J.H. Wang, G. Wagner, and E.L. Reinherz HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane Immunity 28 2008 52 63
164. L.K. Tamm Hypothesis: spring-loaded boomerang mechanism of influenza hemagglutinin-mediated membrane fusion Biochim. Biophys. Acta 1614 2003 14 23
165. L.K. Tamm, and X. Han Viral fusion peptides: a tool set to disrupt and connect biological membranes Biosci. Rep. 20 2000 501 518
166. L.K. Tamm, X. Han, Y. Li, and A.L. Lai Structure and function of membrane fusion peptides Biopolymers 66 2002 249 260
167. L.K. Tamm, A.L. Lai, and Y. Li Combined NMR and EPR spectroscopy to determine structures of viral fusion domains in membranes Biochim. Biophys. Acta 1768 2007 3052 3060
168. B.G. Tenchov, R.C. MacDonald, and B.R. Lentz Fusion peptides promote formation of bilayer cubic phases in lipid dispersions. An x-ray diffraction study Biophys. J. 104 2013 1029 1037
169. S. Tristram-Nagle, R. Chan, E. Kooijman, P. Uppamoochikkal, W. Qiang, D.P. Weliky, and J.F. Nagle HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics J. Mol. Biol. 402 2010 139 153
170. S. Tristram-Nagle, and J.F. Nagle HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates Biophys. J. 93 2007 2048 2055
171. 2-terminal segment during influenza virus-induced membrane fusion J. Biol. Chem. 267 1992 20225 20232
172. M.C. Vaney, and F.A. Rey Class II enveloped viruses Cell. Microbiol. 13 2011 1451 1459
173. S.A. Vishwanathan, and E. Hunter Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion J. Virol. 82 2008 5118 5126
174. T. Weber, G. Paesold, C. Galli, R. Mischler, G. Semenza, and J. Brunner Evidence for H(+)-induced insertion of influenza hemagglutinin HA2 N-terminal segment into viral membrane J. Biol. Chem. 269 1994 18353 18358
175. W. Weissenhorn, A. Dessen, S.C. Harrison, J.J. Skehel, and D.C. Wiley Atomic structure of the ectodomain from HIV-1 gp41 Nature 387 1997 426 430
176. W. Weissenhorn, A. Hinz, and Y. Gaudin Virus membrane fusion FEBS Lett. 581 2007 2150 2155
177. Y. Wexler-Cohen, B.T. Johnson, A. Puri, R. Blumenthal, and Y. Shai Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178 J. Biol. Chem. 281 2006 9005 9010
178. Y. Wexler-Cohen, K. Sackett, and Y. Shai The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils Biochemistry 44 2005 5853 5861
179. J.M. White Membrane fusion Science 258 1992 917 924
180. J.M. White, S.E. Delos, M. Brecher, and K. Schornberg Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme Crit. Rev. Biochem. Mol. Biol. 43 2008 189 219
181. S.H. White, and W.C. Wimley Membrane protein folding and stability: physical principles Annu. Rev. Biophys. Biomol. Struct. 28 1999 319 365
182. C.T. Wild, D.C. Shugars, T.K. Greenwell, C.B. McDanal, and T.J. Matthews Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection Proc. Natl. Acad. Sci. U.S.A. 91 1994 9770 9774
183. D.C. Wiley, and J.J. Skehel The structure and function of the hemagglutinin membrane glycoprotein of influenza virus Annu. Rev. Biochem. 56 1987 365 394
184. J. Yang, C.M. Gabrys, and D.P. Weliky Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide Biochemistry 40 2001 8126 8137
185. J. Yang, M. Prorok, F.J. Castellino, and D.P. Weliky Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers Biophys. J. 87 2004 1951 1963
186. R. Yang, M. Prorok, F.J. Castellino, and D.P. Weliky A trimeric HIV-1 fusion peptide construct which does not self-associate in aqueous solution and which has 15-fold higher membrane fusion rate J. Am. Chem. Soc. 126 2004 14722 14723
187. R. Yang, J. Yang, and D.P. Weliky Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides Biochemistry 42 2003 3527 3535
188. H. Yao, and M. Hong Membrane-dependent conformation, dynamics, and lipid interactions of the fusion peptide of the paramyxovirus PIV5 from solid-state NMR J. Mol. Biol. 425 2013 563 576
189. H.S. Yin, X. Wen, R.G. Paterson, R.A. Lamb, and T.S. Jardetzky Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation Nature 439 2006 38 44
190. J. Zimmerberg, S.S. Vogel, and L.V. Chernomordik Mechanisms of membrane fusion Annu. Rev. Biophys. Biomol. Struct. 22 1993 433 466